Structured evidence table for Astragalus Immune Support Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Astragalus Immune Support Meta-Analysis | The medical burden associated with acute exacerbations has become a major public health challenge (). | 1 | Zhang Qianqian (2026) | Efficacy of Yupingfeng powder in the treatment of bronchial asthma in adults: a systematic review and meta‐analysis |
| Astragalus Immune Support Meta-Analysis | Poor long-term control leads to progressive decline in lung function, increasing the risk of acute exacerbations and death (). | 1 | Zhang Qianqian (2026) | Efficacy of Yupingfeng powder in the treatment of bronchial asthma in adults: a systematic review and meta‐analysis |
| Astragalus Immune Support Meta-Analysis | However, clinical challenges remain: long-term ICS use may lead to adverse effects such as osteoporosis (), 10%–15% of patients have “refractory asthma” (), overuse of SABA is associated with disease exacerbation (), and some patients exhibit poor medication adherence. | 1 | Zhang Qianqian (2026) | Efficacy of Yupingfeng powder in the treatment of bronchial asthma in adults: a systematic review and meta‐analysis |
| Astragalus Immune Support Meta-Analysis | et al., 2025 Huang et al., 2019 Eger et al., 2022 Bronchial asthma is a highly prevalent respiratory disease worldwide, characterized by chronic airway inflammation, airway hyperresponsiveness, reversible airflow limitation, and airway remodeling, driven by both genetic and environmental factors (). | 1 | Zhang Qianqian (2026) | Efficacy of Yupingfeng powder in the treatment of bronchial asthma in adults: a systematic review and meta‐analysis |
| Astragalus Immune Support Meta-Analysis | 5 6 7 8 9 Aging is accompanied by a progressive decline in cellular and organ function, leading to an increased incidence of chronic diseases and neurodegenerative disorders. | 4 | Kanubaddi Kiran Reddy (2026) | Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders |
| Astragalus Immune Support Meta-Analysis | These conditions frequently coexist, and many individuals over the age of 60 present with multiple comorbidities that require combination therapies, which can complicate treatment strategies and increase the risk of drug interactions [,]. | 4 | Kanubaddi Kiran Reddy (2026) | Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders |
| Astragalus Immune Support Meta-Analysis | Astragalus Cordyceps 13 18 Althoughis a plant-derived medicine andis a fungus-derived medicine, both have been reported to regulate biological mechanisms closely associated with aging, including oxidative stress, chronic inflammation, mitochondrial dysfunction, metabolic imbalance, immune dysregulation, and neuroinflammatory injury [,]. | 4 | Kanubaddi Kiran Reddy (2026) | Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders |
| Astragalus Immune Support Meta-Analysis | 1 2 3 4 Traditional Chinese herbal medicines have been widely used for centuries due to their long history, broad accessibility, and rich chemical diversity. | 4 | Kanubaddi Kiran Reddy (2026) | Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders |
Source documents